SCHEMBL4792453

SCHEMBL4792453

N=Cc1c(N)cccc1NCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.51
▸ HSD17B10 Q99714 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HDAC1 Q13547 4/20 0.40
▸ HDAC3 O15379 2/20 0.40
▸ HDAC2 Q92769 2/20 0.40
▸ NCOR2 Q9Y618 1/20 0.40
▸ NSD2 O96028 3/20 0.39
▸ GPR68 Q15743 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ EP300 Q09472 1/20 0.39
▸ MEF2D Q14814 1/20 0.39
▸ NCOR1 O75376 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ IDO1 P14902 2/20 0.38
▸ CA12 O43570 2/20 0.38
▸ CA2 P00918 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22084443 0.79 BACE1 (0.40) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL29922357 0.79 BACE1 (0.65) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL396451 0.79 BACE1 (0.65) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL18930965 0.74 HSD17B10 (0.53) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL7164883 0.73 BACE1 (0.56) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL30464743 0.72 HSD17B10 (0.71) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL4571036 0.72 HSD17B10 (0.71) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL19790198 0.72 PTGER4 (0.43) HSD17B10KDM4EHPGD
SCHEMBL7169755 0.72 BACE1 (0.51) BACE1HSD17B10KDM4EHPGDTSHR
SCHEMBL21137032 0.72 CYP3A4 (0.34) HSD17B10KDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2012779-B1 PROCESS FOR THE PREPARATION OF INDAZOLYL UREAS THAT INHIBIT VANILLOID SUBTYPE 1 (VR1) RECEPTORS ABBOTT LAB (US) 2012-05-16 — — EP disclosed
Send feedback